Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Contemporary Medicinal Chemistry Strategies for the Discovery and Development of Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors
Zhao Wang, Srinivasulu Cherukupalli, Minghui Xie, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 5, pp. 3729-3757
Open Access | Times Cited: 50

Showing 26-50 of 50 citing articles:

Synthetic approaches and application of clinically approved small-molecule Anti-HIV drugs: An update
Lu Sun, Peng Nie, Luan Li, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115847-115847
Closed Access | Times Cited: 5
Lead Optimization and Avoidance of Metabolic-perturbing Motif Developing Novel Diarylpyrimidines as Potent HIV-1 NNRTIs
Yanying Sun, Zhenzhen Zhou, Da Feng, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 23, pp. 15608-15626
Closed Access | Times Cited: 9
Structure-based design and optimization lead to the identification of novel dihydrothiopyrano[3,2-d]pyrimidine derivatives as potent HIV-1 inhibitors against drug-resistant variants
Zhao Wang, Heng Zhang, Zhen Gao, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 3, pp. 1257-1282
Open Access | Times Cited: 5
Structure-guided design of novel HEPT analogs with enhanced potency and safety: From Isopropyl-HEPTs to Cyclopropyl-HEPTs
Ruo-Lan Zhou, Zhiran Ju, Christophe Pannecouque, et al.
European Journal of Medicinal Chemistry (2022) Vol. 246, pp. 114939-114939
Closed Access | Times Cited: 8
Design, synthesis, and mechanistic study of 2-piperazineone-bearing peptidomimetics as novel HIV capsid modulators
Xujie Zhang, Lin Sun, Shujing Xu, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 7, pp. 1272-1295
Open Access | Times Cited: 4
Design, synthesis, and biological evaluation of benzo[4,5]thieno[2,3-d]pyrimidine derivatives as novel HIV-1 NNRTIs
Bairu Meng, Zongji Zhuo, Han Yu, et al.
Chinese Chemical Letters (2023) Vol. 35, Iss. 6, pp. 108827-108827
Closed Access | Times Cited: 4
Emerging insights into pyrazoline motifs: A comprehensive exploration of biological mechanisms and prospects for future advancements
Hesham A. Abou‐Zied, Eman A. M. Beshr, Alaa M. Hayallah, et al.
Journal of Molecular Structure (2023) Vol. 1296, pp. 136807-136807
Closed Access | Times Cited: 4
Design and optimization of piperidine-substituted thiophene[3,2-d]pyrimidine-based HIV-1 NNRTIs with improved drug resistance and pharmacokinetic profiles
Yanying Sun, Zhenzhen Zhou, Zhongling Shi, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 3110-3124
Open Access | Times Cited: 1
High-confidence placement of low-occupancy fragments into electron density using the anomalous signal of sulfur and halogen atoms
Shumeng Ma, Shymaa Damfo, Matthew W. Bowler, et al.
Acta Crystallographica Section D Structural Biology (2024) Vol. 80, Iss. 6, pp. 451-463
Open Access | Times Cited: 1
"Epidemiology, Phylogeny and Drug Resistance Against Human Immuno-Deficiency Virus in Pakistan"
Muhammad Waqar Mazhar
Biomedical Journal of Scientific & Technical Research (2024) Vol. 56, Iss. 2
Open Access | Times Cited: 1
Design, Synthesis, and Mechanistic Study of 2-Pyridone-Bearing Phenylalanine Derivatives as Novel HIV Capsid Modulators
Xujie Zhang, Lin Sun, Shujing Xu, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7640-7640
Open Access | Times Cited: 7
Expansion of the S–CN-DABO scaffold to exploit the impact on inhibitory activities against the non-nucleoside HIV-1 reverse transcriptase
Ling Xu, Qingqing Hao, Christophe Pannecouque, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114512-114512
Closed Access | Times Cited: 6
Design, synthesis, and biological testing of biphenylmethyloxazole inhibitors targeting HIV-1 reverse transcriptase
Zachary J. Carter, Klarissa Hollander, Krasimir A. Spasov, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 84, pp. 129216-129216
Open Access | Times Cited: 3
Discovery and Mechanistic Investigation of Piperazinone Phenylalanine Derivatives with Terminal Indole or Benzene Ring as Novel HIV-1 Capsid Modulators
Shujing Xu, Lin Sun, Waleed A. Zalloum, et al.
Molecules (2022) Vol. 27, Iss. 23, pp. 8415-8415
Open Access | Times Cited: 5
Development of novel S-N3-DABO derivatives as potent non-nucleoside reverse transcriptase inhibitors with improved potency and selectivity
Ling Xu, Qingqing Hao, Wenjuan Huang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 247, pp. 115042-115042
Closed Access | Times Cited: 4
Development of novel HEPT analogs featuring significantly improved anti-resistance potency against HIV-1 through chemical space exploration of the tolerant region I
Ruo-Lan Zhou, Christophe Pannecouque, Erik De Clercq, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106783-106783
Closed Access | Times Cited: 2
Structure-Based Discovery and Characterization of a Preclinical Drug Candidate for the Treatment of HIV-1 Infection
Dongwei Kang, Jinxuan Yang, Lingjin Kong, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2390-2390
Open Access | Times Cited: 3
Identification of Boronate-Containing Diarylpyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
Da Feng, Hao Lin, Liyang Jiang, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7538-7538
Open Access | Times Cited: 3
Investigation of etravirine uptake and distribution in single aortic endothelial cells in vitro means by Raman imaging
Jagoda Orleanska, Wiktoria Wiecek, Katarzyna Majzner
The Analyst (2024) Vol. 149, Iss. 17, pp. 4454-4463
Closed Access
Structure‐based design, synthesis, and biological characterization of indolylarylsulfone derivatives as novel human immunodeficiency virus type 1 inhibitors with potent antiviral activities and favorable drug‐like profiles
Zhao Wang, Wenbo Wang, Zhen Gao, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 8
Closed Access
Doravirine (Pifeltro): A Third‐Generation Non‐Nucleoside Reverse Transcriptase Inhibitor as a Treatment of HIV ‐1 Infection

(2024), pp. 29-52
Closed Access
Synthesis and Design of novel morpholinyl mannich bases for Potential Inhibitory Activity of SARS-CoV-2 Main Protease
Mohamed R. Elamin, Sondos Abdullah J Almahmoud, Tarek A. Yousef, et al.
Oriental Journal Of Chemistry (2023) Vol. 39, Iss. 2, pp. 284-289
Open Access | Times Cited: 1
The current progress in the use of boron as a platform for novel antiviral drug design
Shuo Wang, Yujie Ren, Zhao Wang, et al.
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 12, pp. 1329-1340
Closed Access | Times Cited: 2
<i>In Situ</i> Click Chemistry-Based Discovery of 1,2,3-Triazole-Derived Diarylpyrimidines as Novel HIV-1 NNRTIS by Exploiting the Tolerant Region I in Binding Pocket
Yanying Sun, Da Feng, Zhenzhen Zhou, et al.
(2023)
Closed Access
Expansion of the <i>S</i>-CN-DABO Scaffold to Exploit the Impact on Inhibitory Activities Against the Non-Nucleoside HIV-1 Reverse Transcriptase
Ling Xu, Qingqing Hao, Christophe Pannecouque, et al.
SSRN Electronic Journal (2022)
Closed Access
Previous Page - Page 2

Scroll to top